COPD Connect
  • Saved

1yr
Boston Chest 2024: Key Research Highlights in Sarcoidosis, Asthma, COPD, and Lung Cancer

In this video from the Boston Chest 2024 Conference, Dr. Jack D. Buckley, a pulmonary and critical care physician and professor at Western Michigan University, and Dr. Arianne Baldamero, a staff physician at the Minneapolis VA and assistant professor at the University of Minnesota, present cutting-edge research. They explore advancements in sarcoidosis treatment, novel biomarkers for asthma and COPD management, and innovative lung cancer therapies. Additionally, they highlight healthcare disparities in access to care and technology between urban and rural populations. These findings offer clinicians valuable insights to enhance treatment strategies for a variety of pulmonary disorders.

  • 1yr
    the first line therapy here based on presentation and lung function would be a LAMA/LABA, in addition to the usual care/feeding of the patient (diet, exercise, pulmonary rehab, smoking cessation, Show More
  • Saved

1yr
Electrocardiographic alterations in chronic obstructive pulmonary disease - PubMed

Electrocardiographic alterations in chronic obstructive pulmonary disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38865856/

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and its incidence has grown within several years, quickly becoming the third leading cause of mortality. The...

COPD, a leading cause of morbidity and mortality, affects heart function. ECG abnormalities, including P-wave and QRS axis changes, should be routinely assessed for heart disease in COPD patients.

  • Saved

1yr
Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians - PubMed

Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38460708/

Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disease characterized by progressive airflow limitation and chronic inflammation. The progressive development and long-term repeated acute exacerbation of COPD make many...

This article reviews the relationship between COPD and airway microbiome, exploring mechanisms, treatment implications, and the microbiome's predictive value for disease progression, exacerbation, and clinical management guidance.

  • Saved

1yr
Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases

Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases

Source : https://pubmed.ncbi.nlm.nih.gov/38561090/

Metabolic reprogramming underlies the etiology and pathophysiology of respiratory diseases such as asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). The dysregulated cellular activities driving airway inflammation...

Targeting metabolic pathways, particularly glycolysis and oxidative phosphorylation, presents a promising therapeutic approach for asthma, IPF, and COPD, warranting further clinical validation to explore their efficacy and mechanisms.

  • Saved

1yr
Nutritional Support and Physical Activity Intervention Programs with a Person-Centred Approach in People with Chronic Obstructive Pulmonary Disease: a Scoping Review

Nutritional Support and Physical Activity Intervention Programs with a Person-Centred Approach in People with Chronic Obstructive Pulmonary Disease: a Scoping Review

Source : https://pubmed.ncbi.nlm.nih.gov/39371918/

This scoping review addresses a knowledge gap in nutritional support interventions with a person-centred approach. It indicates that there is a need to increase nutritional support and consider the patient's...

This scoping review highlights the need for improved nutritional support and tailored interventions in COPD management, emphasizing a person-centred approach to enhance physical activity and leverage patient resources.